Cargando…
Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants
Usher syndrome (USH) is an autosomal recessively inherited disease characterized by sensorineural hearing loss (SNHL) and retinitis pigmentosa (RP) with or without vestibular dysfunction. It is highly heterogeneous both clinically and genetically. Recently, variants in the arylsulfatase G (ARSG) gen...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556359/ https://www.ncbi.nlm.nih.gov/pubmed/35226187 http://dx.doi.org/10.1007/s00439-022-02441-0 |
_version_ | 1784807060579287040 |
---|---|
author | Velde, Hedwig M. Reurink, Janine Held, Sebastian Li, Catherina H. Z. Yzer, Suzanne Oostrik, Jaap Weeda, Jack Haer-Wigman, Lonneke Yntema, Helger G. Roosing, Susanne Pauleikhoff, Laurenz Lange, Clemens Whelan, Laura Dockery, Adrian Zhu, Julia Keegan, David J. Farrar, G. Jane Kremer, Hannie Lanting, Cornelis P. Damme, Markus Pennings, Ronald J. E. |
author_facet | Velde, Hedwig M. Reurink, Janine Held, Sebastian Li, Catherina H. Z. Yzer, Suzanne Oostrik, Jaap Weeda, Jack Haer-Wigman, Lonneke Yntema, Helger G. Roosing, Susanne Pauleikhoff, Laurenz Lange, Clemens Whelan, Laura Dockery, Adrian Zhu, Julia Keegan, David J. Farrar, G. Jane Kremer, Hannie Lanting, Cornelis P. Damme, Markus Pennings, Ronald J. E. |
author_sort | Velde, Hedwig M. |
collection | PubMed |
description | Usher syndrome (USH) is an autosomal recessively inherited disease characterized by sensorineural hearing loss (SNHL) and retinitis pigmentosa (RP) with or without vestibular dysfunction. It is highly heterogeneous both clinically and genetically. Recently, variants in the arylsulfatase G (ARSG) gene have been reported to underlie USH type IV. This distinct type of USH is characterized by late-onset RP with predominantly pericentral and macular changes, and late onset SNHL without vestibular dysfunction. In this study, we describe the USH type IV phenotype in three unrelated subjects. We identified three novel pathogenic variants, two novel likely pathogenic variants, and one previously described pathogenic variant in ARSG. Functional experiments indicated a loss of sulfatase activity of the mutant proteins. Our findings confirm that ARSG variants cause the newly defined USH type IV and support the proposed extension of the phenotypic USH classification. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00439-022-02441-0. |
format | Online Article Text |
id | pubmed-9556359 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-95563592022-10-14 Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants Velde, Hedwig M. Reurink, Janine Held, Sebastian Li, Catherina H. Z. Yzer, Suzanne Oostrik, Jaap Weeda, Jack Haer-Wigman, Lonneke Yntema, Helger G. Roosing, Susanne Pauleikhoff, Laurenz Lange, Clemens Whelan, Laura Dockery, Adrian Zhu, Julia Keegan, David J. Farrar, G. Jane Kremer, Hannie Lanting, Cornelis P. Damme, Markus Pennings, Ronald J. E. Hum Genet Original Investigation Usher syndrome (USH) is an autosomal recessively inherited disease characterized by sensorineural hearing loss (SNHL) and retinitis pigmentosa (RP) with or without vestibular dysfunction. It is highly heterogeneous both clinically and genetically. Recently, variants in the arylsulfatase G (ARSG) gene have been reported to underlie USH type IV. This distinct type of USH is characterized by late-onset RP with predominantly pericentral and macular changes, and late onset SNHL without vestibular dysfunction. In this study, we describe the USH type IV phenotype in three unrelated subjects. We identified three novel pathogenic variants, two novel likely pathogenic variants, and one previously described pathogenic variant in ARSG. Functional experiments indicated a loss of sulfatase activity of the mutant proteins. Our findings confirm that ARSG variants cause the newly defined USH type IV and support the proposed extension of the phenotypic USH classification. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00439-022-02441-0. Springer Berlin Heidelberg 2022-02-28 2022 /pmc/articles/PMC9556359/ /pubmed/35226187 http://dx.doi.org/10.1007/s00439-022-02441-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Investigation Velde, Hedwig M. Reurink, Janine Held, Sebastian Li, Catherina H. Z. Yzer, Suzanne Oostrik, Jaap Weeda, Jack Haer-Wigman, Lonneke Yntema, Helger G. Roosing, Susanne Pauleikhoff, Laurenz Lange, Clemens Whelan, Laura Dockery, Adrian Zhu, Julia Keegan, David J. Farrar, G. Jane Kremer, Hannie Lanting, Cornelis P. Damme, Markus Pennings, Ronald J. E. Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants |
title | Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants |
title_full | Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants |
title_fullStr | Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants |
title_full_unstemmed | Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants |
title_short | Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants |
title_sort | usher syndrome type iv: clinically and molecularly confirmed by novel arsg variants |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556359/ https://www.ncbi.nlm.nih.gov/pubmed/35226187 http://dx.doi.org/10.1007/s00439-022-02441-0 |
work_keys_str_mv | AT veldehedwigm ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants AT reurinkjanine ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants AT heldsebastian ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants AT licatherinahz ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants AT yzersuzanne ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants AT oostrikjaap ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants AT weedajack ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants AT haerwigmanlonneke ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants AT yntemahelgerg ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants AT roosingsusanne ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants AT pauleikhofflaurenz ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants AT langeclemens ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants AT whelanlaura ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants AT dockeryadrian ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants AT zhujulia ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants AT keegandavidj ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants AT farrargjane ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants AT kremerhannie ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants AT lantingcornelisp ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants AT dammemarkus ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants AT penningsronaldje ushersyndrometypeivclinicallyandmolecularlyconfirmedbynovelarsgvariants |